Trial Profile
An Open-Label, Single-Dose, Randomized, Four-Way Crossover Study In Healthy Volunteers To Evaluate The Effects Of A Low, Medium And High Fat Evening Meal On The Pharmacokinetics Of Pregabalin Controlled Release Formulation As Compared To The Immediate Release Formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Epilepsy; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 08 Oct 2018 New trial record
- 03 May 2011 Status changed from active, no longer recruiting to completed.